Portage Biotech Inc. - Common Stock (PRTG)
4.5600
0.00 (0.00%)
Portage Biotech Inc is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of cancer
The company is dedicated to advancing its proprietary drug candidates through various stages of clinical development, aiming to address unmet medical needs in oncology. By leveraging its scientific expertise and strategic partnerships, Portage is engaged in researching and developing novel immunotherapies and personalized medicine approaches that aim to improve patient outcomes and enhance the efficacy of existing cancer treatments.
Frequently Asked Questions
Is Portage Biotech Inc. - Common Stock publicly traded?
Yes, Portage Biotech Inc. - Common Stock is publicly traded.
What exchange does Portage Biotech Inc. - Common Stock trade on?
Portage Biotech Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Portage Biotech Inc. - Common Stock?
The ticker symbol for Portage Biotech Inc. - Common Stock is PRTG on the Nasdaq Stock Market
What is the current price of Portage Biotech Inc. - Common Stock?
The current price of Portage Biotech Inc. - Common Stock is 4.560
When was Portage Biotech Inc. - Common Stock last traded?
The last trade of Portage Biotech Inc. - Common Stock was at 4:00 pm EST on January 30th, 2025